Search

Author/Creator Balakrishnan, Anand

1. Chronic eosinophilic leukemia with recurrent STAT5B N642H mutation—An entity with features of myelodysplastic syndrome/ myeloproliferative neoplasm overlap. (January 2022)

Authors:
Sreedharanunni, Sreejesh; Jamwal, Manu; Balakrishnan, Anand; Aravindan, Arun Vijayalakshmi; Sharma, Ritika; Singh, Namrata; Rajpal, Sweta; Singla, Shelly; Khadwal, Alka Rani; Ahluwalia, Jasmina; Malhotra, Pankaj; Das, Reena
Journal:
Leukemia research
Issue:
Volume 112(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Difluorocyclobutylacetylenes as positive allosteric modulators of mGluR5 with reduced bioactivation potential. Issue 24 (15th December 2016)

Authors:
Degnan, Andrew P.; Maxwell, Darrell; Balakrishnan, Anand; Brown, Jeffrey M.; Easton, Amy; Gulianello, Michael; Hanumegowda, Umesh; Hill-Drzewi, Melissa; Miller, Regina; Santone, Kenneth S.; Senapati, Arun; Shields, Eric E.; Sivarao, Digavalli V.; Westphal, Ryan; Whiterock, Valerie J.; Zhuo, Xiaol...
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 26:Issue 24(2016)
Page Start:
5871
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box. Issue 17 (1st September 2016)

Authors:
Huang, Hong; Degnan, Andrew P.; Balakrishnan, Anand; Easton, Amy; Gulianello, Michael; Huang, Yanling; Matchett, Michele; Mattson, Gail; Miller, Regina; Santone, Kenneth S.; Senapati, Arun; Shields, Eric E.; Sivarao, Digavalli V.; Snyder, Lawrence B.; Westphal, Ryan; Whiterock, Valerie J.; Yang, ...
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 26:Issue 17(2016)
Page Start:
4165
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS‐650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor. Issue 9 (28th January 2015)

Authors:
Mosure, Kathleen W.; Knipe, Jay O.; Browning, Marc; Arora, Vinod; Shu, Yue‐Zhong; Phillip, Thomas; Mcphee, Fiona; Scola, Paul; Balakrishnan, Anand; Soars, Matthew G.; Santone, Kenneth; Sinz, Michael; Donovan, Maureen D.; Langguth, Peter; Polli, James E.; Tamai, Ikumi; Vig, Balvinder; Yu, Lawrence X.
Journal:
Journal of pharmaceutical sciences
Issue:
Volume 104:Issue 9(2015:Sep.)
Page Start:
2813
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The success rate of interphase fluorescence in situ hybridization in plasma cell disorders can be improved using unconventional sources of plasma cells. (11th October 2021)

Authors:
Panakkal, Vandana; Rana, Sonia; Rathore, Shailja; Anshu, Anshu; Balakrishnan, Anand; Singh, Charanpreet; Jandial, Aditya; Sachdeva, Man Updesh Singh; Varma, Neelam; Lad, Deepesh; Malhotra, Pankaj; Sreedharanunni, Sreejesh
Journal:
International journal of laboratory hematology
Issue:
Volume 44:Number 1(2022)
Page Start:
157
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗